Association of Inflammatory Bowel Disease (IBD) with Depressive Symptoms in the United States Population and Independent Predictors of Depressive Symptoms in an IBD Population: A NHANES Study
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background/Aims: There is a paucity of population-based studies on the association between inflammatory bowel disease (IBD) and depression in the U.S. population. We sought to study this association using the National Health and Nutrition Examination Survey (NHANES) database. Methods: We used NHANES data from 2009 to 2010. Our study included 190,269,933 U.S. adults without IBD and 2,325,226 with IBD. We sought to determine whether IBD is an independent risk factor for depressive symptoms (DS) in the U.S. population and studied the independent predictors of DS in IBD population. Results: DS was present in 49% of the IBD population versus 23% of the non-IBD population (p<0.001). During the multivariate analysis, we found that IBD was independently associated with DS in the U.S. population (p=0.002). The independent predictors of DS in the IBD population were older age (p=0.048) and divorced/separated/widowed status (p=0.005). There was nonsignificant increase in suicidal risk in IBD population with DS versus that in non-IBD population with DS (27% vs 12%, respectively, p=0.080). Only 36% of IBD individuals with DS visited mental health professional or psychiatrist within the past year. Conclusions: IBD is independently associated with DS in the U.S. population. Further research is warranted on risk stratification, screening and management of those with IBD who are at risk of depression.
Abstract
Background/Aims: There is a paucity of population-based studies on the association between inflammatory bowel disease (IBD) and depression in the U.S. population. We sought to study this association using the National Health and Nutrition Examination Survey (NHANES) database. Methods: We used NHANES data from 2009 to 2010. Our study included 190,269,933 U.S. adults without IBD and 2,325,226 with IBD. We sought to determine whether IBD is an independent risk factor for depressive symptoms (DS) in the U.S. population and studied the independent predictors of DS in IBD population. Results: DS was present in 49% of the IBD population versus 23% of the non-IBD population (p<0.001). During the multivariate analysis, we found that IBD was independently associated with DS in the U.S. population (p=0.002). The independent predictors of DS in the IBD population were older age (p=0.048) and divorced/separated/widowed status (p=0.005). There was nonsignificant increase in suicidal risk in IBD population with DS versus that in non-IBD population with DS (27% vs 12%, respectively, p=0.080). Only 36% of IBD individuals with DS visited mental health professional or psychiatrist within the past year. Conclusions: IBD is independently associated with DS in the U.S. population. Further research is warranted on risk stratification, screening and management of those with IBD who are at risk of depression.
참고문헌 (31)
- Loftus EV Jr, "Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences", Gastroenterology, 126, pp.1504~1517 (2004)
- Kappelman MD, "The prevalence and geographic distribution of Crohn’s disease and ulcerative colitis in the United States", Clin Gastroenterol Hepatol, 5, pp.1424~1429 (2007)
- Ganz ML, "The economic and health-related impact of Crohn’s disease in the United States: evidence from a nationally representative survey", Inflamm Bowel Dis, 22, pp.1032~1041 (2016)
- Mowat C, "Guidelines for the management of inflammatory bowel disease in adults", Gut, 60, pp.571~607 (2011)
- Mittermaier C, "Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study", Psychosom Med, 66, pp.79~84 (2004)
- Mawdsley JE, "Psychological stress in IBD: new insights into pathogenic and therapeutic implications", Gut, 54, pp.1481~1491 (2005)
- Bernstein CN, "A prospective population-based study of triggers of symptomatic flares in IBD", Am J Gastroenterol, 105, pp.1994~2002 (2010)
- Nigro G, "Psychiatric predictors of noncompliance in inflammatory bowel disease: psychiatry and compliance", J Clin Gastroenterol, 32, pp.66~68 (2001)
- Persoons P, "The impact of major depressive disorder on the short- and long-term outcome of Crohn’s disease treatment with infliximab", Aliment Pharmacol Ther, 22, pp.101~110 (2005)
- Fuller-Thomson E, "Depression and inflammatory bowel disease: findings from two nationally representative Canadian surveys", Inflamm Bowel Dis, 12, pp.697~707 (2006)
- Kurina LM, "Depression and anxiety in people with inflammatory bowel disease", J Epidemiol Community Health, 55, pp.716~720 (2001)
- "The National Health and Nutrition Examination Survey" (2014)[URL]
- Walker JR, "The Manitoba IBD cohort study: a population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders", Am J Gastroenterol, 103, pp.1989~1997 (2008)
- Graff LA, "Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management", Inflamm Bowel Dis, 15, pp.1105~1118 (2009)
- Sajadinejad MS, "Psychological issues in inflammatory bowel disease: an overview", Gastroenterol Res Pract, 2012, pp.106502~ (2012)
- Levenstein S, "Stress and exacerbation in ulcerative colitis: a prospective study of patients enrolled in remission", Am J Gastroenterol, 95, pp.1213~1220 (2000)
- Simrén M, "Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors", Am J Gastroenterol, 97, pp.389~396 (2002)
- Guthrie E, "Psychological disorder and severity of inflammatory bowel disease predict health-related quality of life in ulcerative colitis and Crohn’s disease", Am J Gastroenterol, 97, pp.1994~1999 (2002)
- Jones MP, "Coping strategies and interpersonal support in patients with irritable bowel syndrome and inflammatory bowel disease", Clin Gastroenterol Hepatol, 4, pp.474~481 (2006)
- Kessler RC, "Prevalence of and risk factors for lifetime suicide attempts in the National Comorbidity Survey", Arch Gen Psychiatry, 56, pp.617~626 (1999)
- Persson PG, "Survival and cause-specific mortality in inflammatory bowel disease: a population-based cohort study", Gastroenterology, 110, pp.1339~1345 (1996)
- Prior P, "Mortality in Crohn’s disease", Gastroenterology, 80, pp.307~312 (1981)
- Gradus JL, "Inflammatory bowel disease and completed suicide in Danish adults", Inflamm Bowel Dis, 16, pp.2158~2161 (2010)
- Goodhand JR, "Do antidepressants influence the disease course in inflammatory bowel disease? A retrospective case-matched observational study", Inflamm Bowel Dis, 18, pp.1232~1239 (2012)
- Mikocka-Walus AA, "Antidepressants and inflammatory bowel disease: a systematic review", Clin Pract Epidemiol Ment Health, 2, pp.24~ (2006)
- McCombie AM, "Psychotherapy for inflammatory bowel disease: a review and update", J Crohns Colitis, 7, pp.935~949 (2013)
- Timmer A, "Psychological interventions for treatment of inflammatory bowel disease", Cochrane Database Syst Rev, (2), pp.CD006913~ (2011)
- Horst S, "Treatment with immunosuppressive therapy may improve depressive symptoms in patients with inflammatory bowel disease", Dig Dis Sci, 60, pp.465~470 (2015)
- Bastida G, "The effects of thiopurine therapy on health-related quality of life in inflammatory bowel disease patients", BMC Gastroenterol, 10, pp.26~ (2010)
- Moscandrew M, "General health maintenance in IBD", Inflamm Bowel Dis, 15, pp.1399~1409 (2009)
- Long MD, "Risk factors for depression in the elderly inflammatory bowel disease population", J Crohns Colitis, 8, pp.113~119 (2014)